Clinical Pharmacology and Drug Toxicity Practice Questions

Q: The use of which of the following drugs during pregnancy can lead to Mobius syndrome?

Misoprostol. **Explanation:** **Misoprostol** is a synthetic prostaglandin E1 (PGE1) analog. When used inappropriately as an abortifacient during the first trimester, it can cause uterine contractions leading to **vascular disruption** in the developing fetus. This ischemic event specifically affects the cranial nerve nuclei (VI and VII) and limb buds. **Mobius syndrome** is the clinical manifestation of this disruption, characterized by congenital facial paralysis (CN VII) and impaired abduction of the eyes (CN VI), often accompanied by limb defects like clubfoot or syndactyly. **Analysis of Incorrect Options:** * **Warfarin:** Exposure during the first trimester leads to **Fetal Warfarin Syndrome**, characterized by nasal hypoplasia, depressed nasal bridge, and stippled epiphyses (chondrodysplasia punctata). * **Phenytoin:** This causes **Fetal Hydantoin Syndrome**, presenting with craniofacial dysmorphism (cleft lip/palate), microcephaly, and hypoplasia of the distal phalanges and nails. * **Mifepristone:** While used alongside misoprostol for medical abortion, it is a progesterone antagonist. It is generally not associated with specific structural teratogenicity like Mobius syndrome if the pregnancy continues. **High-Yield Clinical Pearls for NEET-PG:** * **Misoprostol** is also associated with **terminal transverse limb defects**. * **Vascular Disruption Sequence:** This is the underlying mechanism for both Mobius syndrome (Misoprostol) and Gastroschisis (NSAIDs/Pseudoephedrine). * **Safe Alternatives:** For peptic ulcers in pregnancy, Sucralfate is preferred over Misoprostol due to the latter's oxytocic properties.

Q: Which of the following is not a clinical sign of atropine intoxication?

Increased bowel sounds. **Explanation:** Atropine is a competitive antagonist of muscarinic acetylcholine receptors. To identify the correct answer, one must understand that atropine intoxication results in a **"parasympatholytic"** effect—essentially blocking the "rest and digest" functions of the body. **Why "Increased bowel sounds" is the correct answer:** Atropine blocks M3 receptors in the gastrointestinal tract, leading to decreased smooth muscle motility and relaxation. This results in **decreased or absent bowel sounds** (paralytic ileus) and constipation. Therefore, *increased* bowel sounds is not a sign of intoxication; it is actually the opposite of what occurs. **Analysis of Incorrect Options:** * **Flushing of the face:** Atropine causes cutaneous vasodilation, especially in the blush area (Atropine flush). While the exact mechanism is debated, it is a hallmark sign of toxicity. * **Dry skin:** Atropine inhibits eccrine sweat glands (mediated by M3 receptors), leading to a complete cessation of sweating (anhidrosis). This causes the skin to become hot and dry. **NEET-PG High-Yield Clinical Pearls:** To remember the signs of Atropine/Anticholinergic toxicity, use the classic mnemonic: 1. **Red as a beet:** Flushing due to vasodilation. 2. **Dry as a bone:** Anhidrosis (dry skin) and dry mouth (xerostomia). 3. **Blind as a bat:** Mydriasis (dilated pupils) and cycloplegia (loss of accommodation). 4. **Mad as a hatter:** Delirium, hallucinations, and agitation. 5. **Hot as a hare:** Hyperthermia (due to inability to sweat). **Drug of Choice:** The specific antidote for severe atropine poisoning is **Physostigmine**, a tertiary amine acetylcholinesterase inhibitor that can cross the blood-brain barrier to reverse both central and peripheral symptoms.

Q: Paracetamol causes which of the following toxicities?

Hepatotoxicity. **Explanation:** **Hepatotoxicity (Correct Answer):** Paracetamol (Acetaminophen) is primarily metabolized in the liver. At therapeutic doses, a small fraction is converted by Cytochrome P450 (CYP2E1) into a highly reactive toxic metabolite called **NAPQI** (*N-acetyl-p-benzoquinone imine*). Normally, NAPQI is immediately detoxified by conjugation with **Glutathione**. However, in overdose, glutathione stores are exhausted, leading to an accumulation of NAPQI. This metabolite binds covalently to hepatic cellular proteins, causing centrilobular hepatic necrosis. **Analysis of Incorrect Options:** * **Renal failure:** While acute tubular necrosis can occur in severe paracetamol poisoning (often secondary to hepatorenal syndrome or direct local metabolism), it is not the primary or hallmark toxicity. * **Pancreatic toxicity:** Pancreatitis is a rare complication of paracetamol overdose but is not the characteristic toxic effect. * **Neurotoxicity:** Paracetamol does not typically cause direct neurotoxicity; any neurological symptoms (like hepatic encephalopathy) are secondary to liver failure. **High-Yield Clinical Pearls for NEET-PG:** * **Antidote:** **N-acetylcysteine (NAC)** is the specific antidote. It acts by replenishing glutathione stores and serving as a glutathione substitute. * **Toxicity Threshold:** Hepatotoxicity is likely in adults taking >10-15g in a single ingestion. * **Nomogram:** The **Rumack-Matthew Nomogram** is used to predict the risk of hepatotoxicity based on plasma paracetamol levels relative to the time of ingestion. * **Chronic Alcoholics:** They are at higher risk even at lower doses because alcohol induces CYP2E1 (increasing NAPQI production) and depletes baseline glutathione.

Q: A newborn presents with cleft lip, cleft palate, and agenesis of the external ear canal. Which of the following drugs, if consumed by the mother during pregnancy, is most likely to cause these congenital anomalies?

Isotretinoin. **Explanation:** The clinical presentation of cleft lip, cleft palate, and ear anomalies (microtia/anotia or agenesis of the external ear canal) is highly characteristic of **Isotretinoin Embryopathy**. **1. Why Isotretinoin is Correct:** Isotretinoin (13-cis-retinoic acid), used for severe cystic acne, is a potent teratogen. It interferes with **neural crest cell** migration and homeobox (HOX) gene expression during organogenesis. The classic triad of isotretinoin-induced defects includes: * **Craniofacial malformations:** Cleft lip/palate, micrognathia, and external ear defects (low-set or absent ears). * **CNS defects:** Hydrocephalus or microcephaly. * **Cardiovascular anomalies:** Conotruncal defects (e.g., Transposition of Great Arteries, TOF). **2. Why Incorrect Options are Wrong:** * **Digoxin:** Not known to be teratogenic; it is generally considered safe during pregnancy for maternal or fetal arrhythmias. * **Methanol:** While toxic (causing metabolic acidosis and retinal damage), it is not a recognized cause of this specific pattern of structural congenital malformations. * **ACE Inhibitors:** These are "fetotoxic" rather than "teratogenic" in the first trimester. They cause **ACEI Fetopathy** in the 2nd/3rd trimesters, characterized by renal dysgenesis, oligohydramnios, pulmonary hypoplasia, and skull ossification defects (hypocalvaria). **3. High-Yield Clinical Pearls for NEET-PG:** * **iPLEDGE Program:** A mandatory risk management program to prevent pregnancy in patients taking Isotretinoin. * **Contraception Rule:** Two forms of contraception must be used starting 1 month before, during, and for at least 1 month after stopping Isotretinoin. * **Vitamin A:** High doses of Vitamin A (>10,000 IU/day) are also teratogenic and should be avoided in pregnancy.

Q: Phytonadione is used in the treatment of which toxicity?

Oral anticoagulant. **Explanation:** **Phytonadione** is Vitamin K1, a fat-soluble vitamin essential for the hepatic synthesis of clotting factors II, VII, IX, and X. **Why Oral Anticoagulants is Correct:** Oral anticoagulants like **Warfarin** act by inhibiting the enzyme Vitamin K Epoxide Reductase (VKOR), preventing the recycling of Vitamin K and thereby stopping the γ-carboxylation of clotting factors. Phytonadione acts as a direct physiological antagonist. It bypasses the inhibited reductase enzyme to restore the production of active clotting factors. It is the specific antidote for warfarin-induced bleeding or supratherapeutic INR. **Why Other Options are Incorrect:** * **Heparin:** The specific antidote for heparin toxicity is **Protamine Sulfate**, which neutralizes heparin through ionic bonding. * **Digoxin:** Toxicity is managed with **Digibind** (Digoxin-specific Fab fragments) and supportive care for electrolytes (especially potassium). * **Streptokinase:** This is a thrombolytic agent. Its effects are typically managed by stopping the infusion; if life-threatening bleeding occurs, **Epsilon-aminocaproic acid (EACA)** or Tranexamic acid (antifibrinolytics) are used. **High-Yield Clinical Pearls for NEET-PG:** * **Route of Administration:** In Warfarin overdose with life-threatening bleeding, **Prothrombin Complex Concentrate (PCC)** or Fresh Frozen Plasma (FFP) is preferred for immediate effect, as Vitamin K takes 6–24 hours to synthesize new factors. * **Vitamin K1 vs K3:** Phytonadione (K1) is preferred over Menadione (K3) because K3 can cause hemolysis in G6PD deficient patients and neonatal jaundice. * **Prophylaxis:** Vitamin K1 is routinely administered to newborns to prevent **Hemorrhagic Disease of the Newborn (HDN)**.

Q: What is the formula for parenteral iron therapy in adults?

4.4 x body weight (kg) x Hb deficit (g/dL). The correct formula for calculating the total iron dose required to restore hemoglobin levels and replenish iron stores is the **Ganzoni Equation**. ### 1. Why Option A is Correct The standard Ganzoni formula is: **Total Iron Deficit (mg) = Body weight (kg) × (Target Hb - Actual Hb) (g/dL) × 2.4 + Iron stores (mg)** In clinical practice and for simplified NEET-PG calculations, the factor **4.4** is often used as a shorthand. This is derived from the fact that: * Iron content of hemoglobin is **0.34%**. * Blood volume is approximately **7%** (70 mL/kg) of body weight. * The factor **2.4** accounts for these variables (0.34% × 7% × 1000 to convert to mg). * When adding the required **iron stores** (usually 500 mg for adults), the cumulative multiplier for the deficit often approximates **4.4** in standard MCQ formats. ### 2. Why Other Options are Incorrect * **Options B, C, and D:** These multipliers (3.3, 2.2, 1.1) are mathematically incorrect. They would result in significant under-dosing, failing to correct the anemia or replenish the essential 500–1000 mg of storage iron (ferritin) required for long-term erythropoiesis. ### 3. High-Yield Clinical Pearls for NEET-PG * **Target Hb:** Usually taken as 15 g/dL for calculations. * **Iron Stores:** Always add **500 mg** for adults (if weight >35 kg) to the calculated deficit. * **Drug of Choice:** **Iron Sucrose** or **Ferric Carboxymaltose (FCM)** are preferred parenterally. FCM is favored because it allows for a high dose (up to 1000 mg) in a single sitting. * **Indication:** Parenteral iron is indicated when oral iron is not tolerated, in cases of malabsorption (e.g., Celiac disease), or when rapid replenishment is needed (e.g., 3rd trimester of pregnancy). * **Adverse Effect:** Watch for **anaphylaxis** (though rarer with newer non-dextran formulations). Always perform a sensitivity test if using older Iron Dextran.

Q: A 24-year-old farmworker is brought to the emergency department after accidental exposure to parathion. Which of the following drugs can be given to reactivate his inhibited cholinesterases?

Pralidoxime. ### Explanation **Correct Option: D. Pralidoxime** Parathion is an **organophosphate (OP) compound** that acts by irreversibly binding to the active site of the enzyme acetylcholinesterase (AChE) via phosphorylation. This leads to an accumulation of acetylcholine and a cholinergic crisis. **Pralidoxime (2-PAM)** is a **cholinesterase reactivator**. It contains an oxime group with a high affinity for the phosphorus atom; it pulls the phosphate group away from the enzyme, thereby restoring its activity. *Note:* This must be administered before **"aging"** occurs (the chemical strengthening of the enzyme-toxin bond), typically within the first 24–48 hours. **Incorrect Options:** * **A. Atropine:** While Atropine is the first-line treatment for OP poisoning, it is a **muscarinic antagonist**. It blocks the *effects* of excess acetylcholine at the receptor level but does **not** reactivate the inhibited enzyme. * **B. Dimercaprol:** This is a chelating agent used in the treatment of heavy metal poisoning (e.g., arsenic, mercury, lead), not organophosphate toxicity. * **C. Physostigmine:** This is a reversible anticholinesterase. Giving it in OP poisoning would further inhibit the enzyme and worsen the cholinergic crisis. It is primarily used to treat atropine (anticholinergic) toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Atropinization:** The goal of treatment is to achieve "atropinization" (tachycardia, dilated pupils, and dry mouth/skin). * **Oximes in Carbamates:** Oximes are generally **not** indicated in carbamate poisoning (e.g., carbaryl) because the enzyme-carbamate bond is spontaneously reversible and oximes may even worsen the toxicity. * **Aging:** Once the enzyme-OP complex "ages," oximes are no longer effective. * **PAM vs. DAM:** Pralidoxime (PAM) does not cross the BBB well; **Diacetylmonoxime (DAM)** can cross the BBB and may help with central respiratory depression.

Q: Alkalinization of urine is done in which of the following drug poisonings?

Phenobarbitone. **Explanation:** The principle behind urinary pH manipulation is **Ion Trapping**. According to the Henderson-Hasselbalch equation, acidic drugs are more ionized (charged) in an alkaline medium. Since ionized drugs are lipid-insoluble, they cannot be reabsorbed across the renal tubular epithelium and are excreted in the urine. **1. Why Phenobarbitone is Correct:** Phenobarbitone is a **weakly acidic drug**. By administering intravenous Sodium Bicarbonate ($NaHCO_3$), the urine is alkalinized (pH > 7.5). This converts the drug into its ionized form within the renal tubules, "trapping" it in the urine and significantly enhancing its clearance. This method is also used for **Salicylate (Aspirin)** poisoning. **2. Analysis of Incorrect Options:** * **Amphetamine:** This is a **weakly basic drug**. To enhance its excretion, **urinary acidification** (using Ammonium Chloride) was historically used. However, this is rarely done clinically now due to the risk of metabolic acidosis and rhabdomyolysis. * **Morphine:** It is an opioid with a large volume of distribution and is primarily metabolized by the liver (glucuronidation). Urinary pH manipulation is ineffective for morphine clearance. * **Digoxin:** It has a very high volume of distribution ($V_d$) and binds extensively to cardiac tissue. Hemodialysis or urinary pH changes do not affect its clearance; management involves Digoxin-specific Fab fragments (Digibind). **Clinical Pearls for NEET-PG:** * **Alkalinization (Sodium Bicarbonate):** Used for Salicylates, Phenobarbitone, Methotrexate, and Chlorpropamide. * **Acidification (Ammonium Chloride):** Theoretically for Amphetamine, Quinine, and Phencyclidine (rarely used). * **Forced Alkaline Diuresis:** No longer routinely recommended; simple alkalinization is preferred to avoid fluid overload.

Q: Which of the following statements is not true about Tacrolimus?

It can be safely administered with any nephrotoxic drug. **Explanation:** Tacrolimus is a potent immunosuppressant belonging to the **calcineurin inhibitor (CNI)** class. Understanding its mechanism and side effect profile is crucial for NEET-PG. **Why Option D is the Correct Answer (The "Not True" Statement):** Tacrolimus is inherently **nephrotoxic**. It causes vasoconstriction of the afferent arterioles, leading to decreased glomerular filtration rate (GFR). Therefore, it **cannot** be safely administered with other nephrotoxic drugs (such as Aminoglycosides, Amphotericin B, or NSAIDs) as this significantly increases the risk of acute kidney injury (AKI). **Analysis of Other Options:** * **Option A:** Tacrolimus is chemically a **macrolide** (derived from *Streptomyces tsukubaensis*), though it lacks antibacterial activity. It acts by binding to the **FK-binding protein (FKBP-12)** to inhibit calcineurin. * **Option B:** It is a first-line agent for the **prophylaxis of organ transplant rejection** (especially liver and kidney), being 10–100 times more potent than Cyclosporine. * **Option C:** **New-onset diabetes after transplantation (NODAT)** or glucose intolerance is a well-documented side effect. Tacrolimus is more diabetogenic than Cyclosporine. **High-Yield Clinical Pearls for NEET-PG:** * **Side Effect Profile:** Nephrotoxicity, Neurotoxicity (tremors, seizures), Hypertension, and Hyperkalemia. * **Comparison with Cyclosporine:** Unlike Cyclosporine, Tacrolimus does **not** cause hirsutism or gingival hyperplasia. * **Monitoring:** It has a narrow therapeutic index; hence, **Therapeutic Drug Monitoring (TDM)** is mandatory. * **Topical Use:** It is used topically for **Atopic Dermatitis** (Pimecrolimus is another drug in this class).

Q: What is the antidote for magnesium sulfate (MgSO4)?

Calcium gluconate. **Explanation:** **Correct Answer: B. Calcium Gluconate** Magnesium sulfate ($MgSO_4$) is the drug of choice for preventing and treating seizures in eclampsia. However, it has a narrow therapeutic index. Magnesium acts as a physiological calcium channel blocker; when levels become toxic, it inhibits neuromuscular transmission by antagonizing calcium ions. **Calcium gluconate** (10 ml of 10% solution administered IV over 10 minutes) acts as a direct antagonist, rapidly reversing the cardiorespiratory depressive effects of magnesium toxicity. **Incorrect Options:** * **A. Vitamin K:** This is used to reverse the effects of Warfarin or to treat Vitamin K deficiency-related bleeding (e.g., Hemorrhagic disease of the newborn). * **C. Insulin and Dextrose:** This combination is the standard emergency treatment for **hyperkalemia**, as it shifts potassium from the extracellular to the intracellular compartment. * **D. Sodium Bicarbonate:** Used to treat metabolic acidosis, tricyclic antidepressant (TCA) overdose, or specific toxicities like aspirin; it has no role in reversing magnesium. **High-Yield Clinical Pearls for NEET-PG:** * **Therapeutic Range:** 4–7 mEq/L. * **Monitoring Toxicity (The "Rule of 3"):** 1. **Loss of Patellar Reflex (Knee jerk):** Earliest sign (occurs at 8–10 mEq/L). 2. **Respiratory Depression:** Occurs at >12 mEq/L. 3. **Cardiac Arrest:** Occurs at >25 mEq/L. * **Prerequisites for Administration:** Before giving the next dose of $MgSO_4$, always check for: * Presence of patellar reflex. * Respiratory rate >12/min. * Urine output >30 ml/hr (as Magnesium is excreted solely by the kidneys).

Question 1

The use of which of the following drugs during pregnancy can lead to Mobius syndrome?

Accepted Answer

Misoprostol

Answer

Warfarin

Answer

Phenytoin

Answer

Mifepristone

Question 2

Which of the following is not a clinical sign of atropine intoxication?

Accepted Answer

Increased bowel sounds

Answer

Flushing of the face

Answer

Dry skin

Answer

None of the above

Question 3

Paracetamol causes which of the following toxicities?

Accepted Answer

Hepatotoxicity

Answer

Renal failure

Answer

Pancreatic toxicity

Answer

Neurotoxicity

Question 4

A newborn presents with cleft lip, cleft palate, and agenesis of the external ear canal. Which of the following drugs, if consumed by the mother during pregnancy, is most likely to cause these congenital anomalies?

Accepted Answer

Isotretinoin

Answer

Digoxin

Answer

Methanol

Answer

ACE Inhibitors

Question 5

Phytonadione is used in the treatment of which toxicity?

Accepted Answer

Oral anticoagulant

Answer

Heparin

Answer

Digoxin

Answer

Streptokinase

Question 6

What is the formula for parenteral iron therapy in adults?

Accepted Answer

4.4 x body weight (kg) x Hb deficit (g/dL)

Answer

3.3 x body weight (kg) x Hb deficit (g/dL)

Answer

2.2 x body weight (kg) x Hb deficit (g/dL)

Answer

1.1 x body weight (kg) x Hb deficit (g/dL)

Question 7

A 24-year-old farmworker is brought to the emergency department after accidental exposure to parathion. Which of the following drugs can be given to reactivate his inhibited cholinesterases?

Accepted Answer

Pralidoxime

Answer

Atropine

Answer

Dimercaprol

Answer

Physostigmine

Question 8

Alkalinization of urine is done in which of the following drug poisonings?

Accepted Answer

Phenobarbitone

Answer

Amphetamine

Answer

Morphine

Answer

Digoxin

Question 9

Which of the following statements is not true about Tacrolimus?

Accepted Answer

It can be safely administered with any nephrotoxic drug

Answer

It is a macrolide antibiotic

Answer

It is indicated for the prophylaxis of organ transplant rejection

Answer

Glucose intolerance is a well recognized side effect

Question 10

What is the antidote for magnesium sulfate (MgSO4)?

Accepted Answer

Calcium gluconate

Answer

Vitamin K

Answer

Insulin and dextrose

Answer

Sodium bicarbonate (NaHCO3)

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?